IL6 and COVID-19: Individually, laboratory abnormalities have been reported in COVID-19 patients, including an elevation of inflammatory markers and liver enzymes, abnormal renal function tests, and an elevated serum soluble interleukin 2 (IL-2) receptor (sIL2R) and IL-6.